The 2018 Nobel Prize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation.
James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
Read MoreThe CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference started today with a three and a half day program featuring talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism. The conference can be followed on Twitter #CICON18
Read MoreRegistration and abstract submission are now open online for the Fourth International Cancer Immunotherapy Conference. This joint meeting hosted by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will take place at the New York Marriott Marquis in New York City, September 30 - October 3, 2018.
Read MoreSix junior researchers have been chosen by the CIMT poster jury to receive the 2018 CIMT Poster Awards:
Christof Smith (University of North Carolina at Chapel Hill), Adam Grippin (University of Florida), Daniel Baumann (German Cancer Research Center DKFZ), Jonas Bochem (University Medical Center Tübingen), Julien Schmidt (University of Lausanne) and Chloe Chong (Ludwig Center for Cancer Research)
Read MoreThe 16th Annual Meeting of the Association for Cancer Immunotherapy CIMT has opened with more than 750 academic and clinical professionals from 28 countries in the fields of tumor immunology.
Under the headline “Pushing Frontieres in Cancer Immunotherapy”, the
2018 meeting offers nine plenary sessions on the topics of therapeutic vaccination, CAR T-cell therapy, combination therapies, cellular therapy, counteacting immune escape, immunoguiding, regulatory research, and tumor microenvironment.
AACR and CIMT experts discuss recent research in cancer vaccines at the Cancer Immunology Working Group Town Hall Meeting and Networking Reception today at the AACR Annual Meeting in Chicago.
Read MoreA meeting report on the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (CICON) has been published in the January edition of Cancer Immunology Research. The report provides an overview of the main topics presented at the conference which took place in Mainz/Germany, September 6-9, 2017, and was attended by more than 1,400 people.
Read MoreFor the 16th CIMT Annual Meeting from May 15-17, 2018 in Mainz/Germany the CIMT scientific planning committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity. Please go to www.meeting.cimt.eu for more information.
Read MoreOn October 25, CIMT vice president Prof. Dr. Dr. Cornelis J.M. Melief was awarded an honorary doctorate in medicine by the Johannes Gutenberg University Medical Center in Mainz, Germany. Cornelis (Kees) Melief was honored for his lifetime achievements as a pioneer of tumor immunology, and especially for his contributions to cancer immunology research in Mainz.
Read More